Literature DB >> 19527138

Proteomics of exhaled breath: methodological nuances and pitfalls.

Viktoria S Kurova1, Eldar C Anaev, Alexey S Kononikhin, Kristina Yu Fedorchenko, Igor A Popov, Timothey L Kalupov, Dmitriy O Bratanov, Eugenie N Nikolaev, Sergey D Varfolomeev.   

Abstract

BACKGROUND: The analysis of exhaled breath condensate (EBC) can be an alternative to traditional endoscopic sampling of lower respiratory tract secretions. This is a simple non-invasive method of diagnosing respiratory diseases, in particular, respiratory inflammatory processes.
METHODS: Samples were collected with a special device-condenser (ECoScreen, VIASYS Healthcare, Germany), then treated with trypsin according to the proteomics protocol for standard protein mixtures and analyzed by nanoflow high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) with a 7-Tesla Finnigan LTQ-FT mass spectrometer (Thermo Electron, Germany). Mascot software (Matrixscience) was used for screening the database NCBInr for proteins corresponding to the peptide maps that were obtained.
RESULTS: EBCs from 17 young healthy non-smoking donors were collected. Different methods for concentrating protein were compared in order to optimize EBC preparations for proteomic analysis. The procedure that was chosen allowed identification of proteins exhaled by healthy people. The major proteins in the condensates were cytoskeletal keratins. Another 12 proteins were identified in EBC from healthy non-smokers. Some keratins were found in the ambient air and may be considered exogenous components of exhaled air.
CONCLUSIONS: Knowledge of the normal proteome of exhaled breath allows one to look for biomarkers of different disease states in EBC. Proteins in ambient air can be identified in the respiratory tract and should be excluded from the analysis of the proteome of EBC. The results obtained allowed us to choose the most effective procedure of sample preparation when working with samples containing very low protein concentrations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19527138     DOI: 10.1515/CCLM.2009.166

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  8 in total

1.  Mass Spectrometry Analysis of the Exhaled Breath Condensate and Proposal of Dermcidin and S100A9 as Possible Markers for Lung Cancer Prognosis.

Authors:  Laura Núñez-Naveira; Luis Antonio Mariñas-Pardo; Carmen Montero-Martínez
Journal:  Lung       Date:  2019-05-21       Impact factor: 2.584

2.  Novel Method for Noninvasive Sampling of the Distal Airspace in Acute Respiratory Distress Syndrome.

Authors:  J Brennan McNeil; Ciara M Shaver; V Eric Kerchberger; Derek W Russell; Brandon S Grove; Melissa A Warren; Nancy E Wickersham; Lorraine B Ware; W Hayes McDonald; Julie A Bastarache
Journal:  Am J Respir Crit Care Med       Date:  2018-04-15       Impact factor: 21.405

Review 3.  The state of molecular biomarkers for the early detection of lung cancer.

Authors:  Mohamed Hassanein; J Clay Callison; Carol Callaway-Lane; Melinda C Aldrich; Eric L Grogan; Pierre P Massion
Journal:  Cancer Prev Res (Phila)       Date:  2012-06-11

Review 4.  Proteomic study of acute respiratory distress syndrome: current knowledge and implications for drug development.

Authors:  Joseph E Levitt; Angela J Rogers
Journal:  Expert Rev Proteomics       Date:  2016-04-21       Impact factor: 3.940

Review 5.  Respiratory Proteomics Today: Are Technological Advances for the Identification of Biomarker Signatures Catching up with Their Promise? A Critical Review of the Literature in the Decade 2004-2013.

Authors:  Simona Viglio; Jan Stolk; Paolo Iadarola; Serena Giuliano; Maurizio Luisetti; Roberta Salvini; Marco Fumagalli; Anna Bardoni
Journal:  Proteomes       Date:  2014-01-22

Review 6.  Recent advances in facemask devices for in vivo sampling of human exhaled breath aerosols and inhalable environmental exposures.

Authors:  Bin Hu
Journal:  Trends Analyt Chem       Date:  2022-03-12       Impact factor: 14.908

7.  Profiling the proteome of exhaled breath condensate in healthy smokers and COPD patients by LC-MS/MS.

Authors:  Marco Fumagalli; Fabio Ferrari; Maurizio Luisetti; Jan Stolk; Pieter S Hiemstra; Daniela Capuano; Simona Viglio; Laura Fregonese; Isa Cerveri; Federica Corana; Carmine Tinelli; Paolo Iadarola
Journal:  Int J Mol Sci       Date:  2012-10-29       Impact factor: 5.923

8.  Proteome Profiling of the Exhaled Breath Condensate after Long-Term Spaceflights.

Authors:  Alexey S Kononikhin; Alexander G Brzhozovskiy; Anna M Ryabokon; Kristina Fedorchenko; Natalia V Zhakharova; Alexander I Spasskii; Igor A Popov; Vyacheslav K Ilyin; Zoya O Solovyova; Lyudmila Kh Pastushkova; Alexey V Polyakov; Sergey D Varfolomeev; Irina M Larina; Evgeny N Nikolaev
Journal:  Int J Mol Sci       Date:  2019-09-12       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.